Form 8-K - Current report:
SEC Accession No. 0001564590-19-024412
Filing Date
2019-07-02
Accepted
2019-07-02 16:15:26
Documents
3
Period of Report
2019-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20190701.htm 8-K 35932
2 EX-99.1 vktx-ex991_6.htm EX-99.1 13618
3 GRAPHIC g2umpouvynfu000001.jpg GRAPHIC 3707
  Complete submission text file 0001564590-19-024412.txt   56030
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 19937506
SIC: 2834 Pharmaceutical Preparations